BackFrazier Lifesciences Acquisition Overview

Frazier Lifesciences Acquisition Total Liabilities

Frazier Lifesciences Acquisition's total liabilities is $12M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$12.21M
47.68% YoYΔ $3.94M vs prior year quarter

Peer trimmed avg / median

Loading

Frazier Lifesciences Acquisition Total Liabilities History

Loading

Frazier Lifesciences Acquisition vs. peers: Total Liabilities Comparison

Loading

Frazier Lifesciences Acquisition Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Frazier Lifesciences Acquisition (FLAC) FAQ

As of the most recent data (September 2022), FLAC shows a total liabilities of $12M. That compares with $8.3M in the prior-year period — up 47.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, FLAC's total liabilities is now $12M (was $8.3M) — a 47.7% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Frazier Lifesciences Acquisition is outperforming or lagging.

Tracking FLAC's total liabilities over time shows whether Frazier Lifesciences Acquisition is scaling, shrinking, or reshaping that part of the business. The current reading is $12M That compares with $8.3M in the prior-year period — up 47.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Frazier Lifesciences Acquisition's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $12M) with ownership activity and broader fundamentals.